149 related articles for article (PubMed ID: 33629533)
1. Risk of ocular hypertension in children treated with systemic glucocorticoid.
Krag S; Larsen D; Albertsen BK; Glerup M
Acta Ophthalmol; 2021 Dec; 99(8):e1430-e1434. PubMed ID: 33629533
[TBL] [Abstract][Full Text] [Related]
2. Ocular hypertensive response to topical dexamethasone ointment in children.
Lee YJ; Park CY; Woo KI
Korean J Ophthalmol; 2006 Sep; 20(3):166-70. PubMed ID: 17004631
[TBL] [Abstract][Full Text] [Related]
3. Ocular-hypertensive response to topical steroids in children.
Kwok AK; Lam DS; Ng JS; Fan DS; Chew SJ; Tso MO
Ophthalmology; 1997 Dec; 104(12):2112-6. PubMed ID: 9400772
[TBL] [Abstract][Full Text] [Related]
4. Ocular hypertensive response to topical dexamethasone in children: a dose-dependent phenomenon.
Ng JS; Fan DS; Young AL; Yip NK; Tam K; Kwok AK; Lam DS
Ophthalmology; 2000 Nov; 107(11):2097-100. PubMed ID: 11054340
[TBL] [Abstract][Full Text] [Related]
5. Ocular hypertensive and anti-inflammatory responses to different dosages of topical dexamethasone in children: a randomized trial.
Lam DS; Fan DS; Ng JS; Yu CB; Wong CY; Cheung AY
Clin Exp Ophthalmol; 2005 Jun; 33(3):252-8. PubMed ID: 15932528
[TBL] [Abstract][Full Text] [Related]
6. Incidence of steroid induced-ocular hypertension in postoperative pterygium excision.
Makornwattana M; Suphachearaphan W
J Med Assoc Thai; 2015 Mar; 98 Suppl 2():S151-7. PubMed ID: 26211117
[TBL] [Abstract][Full Text] [Related]
7. A prospective study on ocular hypertensive and antiinflammatory response to different dosages of fluorometholone in children.
Fan DS; Ng JS; Lam DS
Ophthalmology; 2001 Nov; 108(11):1973-7. PubMed ID: 11713064
[TBL] [Abstract][Full Text] [Related]
8. Intraocular pressure fluctuation following intravitreal dexamethasone implant and incidence of secondary ocular hypertension: a Zambian perspective.
Raj P; Kumar K; Balasubramaniam S; Geetha CS; Agarwal A
Pan Afr Med J; 2021; 39():108. PubMed ID: 34512844
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological validation of a feline model of steroid-induced ocular hypertension.
Bhattacherjee P; Paterson CA; Spellman JM; Graff G; Yanni JM
Arch Ophthalmol; 1999 Mar; 117(3):361-4. PubMed ID: 10088814
[TBL] [Abstract][Full Text] [Related]
10. Increased intraocular pressure during treatment for chronic uveitis.
BenEzra D; Wysenbeek YS; Cohen E
Graefes Arch Clin Exp Ophthalmol; 1997 Apr; 235(4):200-3. PubMed ID: 9143886
[TBL] [Abstract][Full Text] [Related]
11. Outcome of Ocular Steroid Hypertensive Response in Children.
Kaur S; Dhiman I; Kaushik S; Raj S; Pandav SS
J Glaucoma; 2016 Apr; 25(4):343-7. PubMed ID: 25651206
[TBL] [Abstract][Full Text] [Related]
12. Incidence and Risk Factors of Elevated Intraocular Pressure Following Deep Anterior Lamellar Keratoplasty.
Huang OS; Mehta JS; Htoon HM; Tan DT; Wong TT
Am J Ophthalmol; 2016 Oct; 170():153-160. PubMed ID: 27519560
[TBL] [Abstract][Full Text] [Related]
13. Age as a risk factor for steroid-induced ocular hypertension in the non-paediatric population.
Choi W; Bae HW; Choi EY; Kim M; Kim EW; Kim CY; Kim M; Seong GJ
Br J Ophthalmol; 2020 Oct; 104(10):1423-1429. PubMed ID: 32071035
[TBL] [Abstract][Full Text] [Related]
14. Steroid-induced ocular hypertension in the pediatric age group.
Al Hanaineh AT; Hassanein DH; Abdelbaky SH; El Zawahry OM
Eur J Ophthalmol; 2018 Jul; 28(4):372-377. PubMed ID: 29554813
[TBL] [Abstract][Full Text] [Related]
15. Incidence, Risk Factors, Treatment, and Outcome of Ocular Hypertension following Intravitreal Steroid Injections: A Comparative Study.
Badrinarayanan L; Rishi P; George R; Isaac N; Rishi E;
Ophthalmologica; 2022; 245(5):431-438. PubMed ID: 35468616
[TBL] [Abstract][Full Text] [Related]
16. Steroid-induced ocular hypertensive response in pediatric patients with acute lymphoblastic leukemia.
Sawada M; Takachi T; Watanabe K; Tsuchiya Y; Nishimura K; Hotta Y; Sato M
Jpn J Ophthalmol; 2023 Jul; 67(4):396-401. PubMed ID: 37310574
[TBL] [Abstract][Full Text] [Related]
17. Incidence of steroid-induced ocular hypertension after vitreoretinal surgery with difluprednate versus prednisolone acetate.
Jeng KW; Fine HF; Wheatley HM; Roth D; Connors DB; Prenner JL
Retina; 2014 Oct; 34(10):1990-6. PubMed ID: 25121927
[TBL] [Abstract][Full Text] [Related]
18. Long-term Outcomes on de novo Ocular Hypertensive Response to Topical Corticosteroids After Corneal Transplantation.
Raj A; Salvador-Culla B; Anwar H; Sykakis E; Figueiredo MS; Figueiredo FC
Cornea; 2020 Jan; 39(1):45-51. PubMed ID: 31517723
[TBL] [Abstract][Full Text] [Related]
19. [Late steroid-induced ocular hypertension after intravitreal dexamethasone implants: A series of 20 cases].
Billant J; Douma I; Agard E; Levron A; Bouvarel H; Leroux P; Badri Y; Dot C
J Fr Ophtalmol; 2023 Nov; 46(9):1039-1046. PubMed ID: 37758545
[TBL] [Abstract][Full Text] [Related]
20. Baseline intraocular pressure: an independent risk factor in severe steroid-induced ocular hypertension after intravitreal dexamethasone implant.
Cho WJ; Lee JM; Bae HW; Kim CY; Seong GJ; Choi W
Graefes Arch Clin Exp Ophthalmol; 2024 Apr; 262(4):1231-1243. PubMed ID: 37930443
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
